Neumora Therapeutics, Inc. (NMRA) Investors: April 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Portfolio Pulse from
A securities class action lawsuit has been filed against Neumora Therapeutics, Inc. (NASDAQ: NMRA) in the Southern District of New York. The lawsuit concerns those who acquired Neumora stock through its IPO on September 15, 2023. The lead plaintiff deadline is April 7, 2025.
March 02, 2025 | 1:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neumora Therapeutics is facing a securities class action lawsuit related to its IPO. This legal action could impact investor confidence and the stock price.
The lawsuit directly targets Neumora's IPO, which could lead to negative sentiment among investors. Legal issues often result in stock price volatility, especially if the outcome is uncertain or potentially costly for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100